ALK-IN-13

• Description :

  ALK-IN-13 is an ALK inhibitor, extracted from patent US20130225528A1, example 19[1].

• UNSPSC :

  12352005

• Target :

  Anaplastic lymphoma kinase (ALK)

• Type :

  Reference compound

• Related Pathways :

  Protein Tyrosine Kinase/RTK

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/alk-in-13.html

• Solubility :

  10 mM in DMSO

• Smiles :

  CN1CCN(C2CCN(C3=CC=C(NC4=NC=C(Cl)C(NC5=CC=C(P(C)(C)=O)C=C5)=N4)C(OC)=C3)CC2)CC1

• Molecular Formula :

  C29H39ClN7O2P

• Molecular Weight :

  584.09

• References & Citations :

  [1]Yihan Wang, et al. Phosphorus Derivatives as Kinase Inhibitors. US20130225528A1.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1197953-88-0]